Literature DB >> 11385615

CD14(dim)/CD16(bright) monocytes in hemophagocytic lymphohistiocytosis.

W Emminger1, G J Zlabinger, G Fritsch, R Urbanek.   

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is an extremely rare and highly lethal chronic inflammatory disease, which is mediated by proinflammatory cytokines. In the peripheral blood of a boy suffering from HLH, a chronic expansion of CD14(dim)/CD16(bright) inflammatory monocytes was detected. Compared with CD14(bright) monocytes, their immunophenotype correlated with more mature monocytic cells differentiating to macrophages: they showed lower expression of CD11b, CD64 and CD35. Such CD14(dim)/CD16(bright) monocytes produce the inflammatory cytokines IL-1beta, IL-6 and TNF-alpha. They fit in well with the pathophysiological concept of HLH as an inflammatory state of lymphocytes and of the monocyte/macrophage system. In the presented patient the percentage of these circulating inflammatory monocytes decreased over time during clinical response to immunosuppressive therapy. This finding may indicate that CD14(dim)/CD16(bright) monocytes represented the degree of inflammation in this extremely rare and highly lethal disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11385615     DOI: 10.1002/1521-4141(200106)31:6<1716::aid-immu1716>3.0.co;2-x

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Alternative activation in systemic juvenile idiopathic arthritis monocytes.

Authors:  Claudia Macaubas; Khoa D Nguyen; Ariana Peck; Julia Buckingham; Chetan Deshpande; Elizabeth Wong; Heather C Alexander; Sheng-Yung Chang; Ann Begovich; Yue Sun; Jane L Park; Kuang-Hung Pan; Richard Lin; Chih-Jian Lih; Erin M Augustine; Carolyn Phillips; Andreas V Hadjinicolaou; Tzielan Lee; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2011-12-28       Impact factor: 3.969

2.  Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes.

Authors:  Gevorg N Tamamyan; Hagop M Kantarjian; Jing Ning; Preetesh Jain; Koji Sasaki; Kenneth L McClain; Carl E Allen; Sherry A Pierce; Jorge E Cortes; Farhad Ravandi; Marina Y Konopleva; Guillermo Garcia-Manero; Christopher B Benton; Dai Chihara; Michael E Rytting; Sa Wang; Waleed Abdelall; Sergej N Konoplev; Naval G Daver
Journal:  Cancer       Date:  2016-05-31       Impact factor: 6.860

3.  Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice.

Authors:  Philippe Krebs; Karine Crozat; Daniel Popkin; Michael B Oldstone; Bruce Beutler
Journal:  Blood       Date:  2011-05-06       Impact factor: 22.113

4.  The successful treatment of haemophagocytic syndrome in patients with human immunodeficiency virus-associated multi-centric Castleman's disease.

Authors:  J Stebbing; S Ngan; H Ibrahim; P Charles; M Nelson; P Kelleher; K N Naresh; M Bower
Journal:  Clin Exp Immunol       Date:  2008-12       Impact factor: 4.330

Review 5.  Viral infections associated with haemophagocytic syndrome.

Authors:  Nadine Rouphael Maakaroun; Abeer Moanna; Jesse T Jacob; Helmut Albrecht
Journal:  Rev Med Virol       Date:  2010-03       Impact factor: 6.989

Review 6.  Infections associated with haemophagocytic syndrome.

Authors:  Nadine G Rouphael; Naasha J Talati; Camille Vaughan; Kelly Cunningham; Roger Moreira; Carolyn Gould
Journal:  Lancet Infect Dis       Date:  2007-12       Impact factor: 25.071

7.  Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology.

Authors:  Jose Gómez-Rial; Maria José Currás-Tuala; Irene Rivero-Calle; Alberto Gómez-Carballa; Miriam Cebey-López; Carmen Rodríguez-Tenreiro; Ana Dacosta-Urbieta; Carmen Rivero-Velasco; Nuria Rodríguez-Núñez; Rocio Trastoy-Pena; Javier Rodríguez-García; Antonio Salas; Federico Martinón-Torres
Journal:  Front Immunol       Date:  2020-09-23       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.